Evidence map›Paper›PMID 40809018›Full record

ArticleFrontiers in oncology2025

Excess mortality in young cancer survivors compared with the general population in Italy: a retrospective study from the Italian population-based cohort of adolescents and young adult cancer survivors.

Paolo Giorgi Rossi, Francesco Marinelli, Pamela Mancuso, Lucia Mangone, Massimo Vicentini, Isabella Bisceglia, Alice Bernasconi, Laura Botta, Annalisa Trama, Ada Working Group

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paolo Giorgi RossiEpidemiology Unit, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Francesco MarinelliEpidemiology Unit, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Pamela MancusoEpidemiology Unit, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Lucia MangoneEpidemiology Unit, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Massimo VicentiniEpidemiology Unit, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Isabella BiscegliaEpidemiology Unit, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Alice BernasconiEvaluative Epidemiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Laura BottaEvaluative Epidemiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Annalisa TramaEvaluative Epidemiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Ada Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Adolescents and young adults (AYA) cancer survivors experience increased morbidity and mortality from second cancers, cardiovascular, infectious, kidney, and other chronic diseases. We aim to calculate all-causes cancer and non-cancer excess mortality of young cancer survivors compared to the general population. Methods: The AYA cohort includes cancer patients diagnosed between 1976 and 2013 and alive at 5 years after diagnosis in 30 population-based Cancer Registries and followed up until 31 December 2019. The standardised mortality ratios (SMRs) and absolute excess risks (AERs) per 100,000 for person-years were calculated. Results: 58,387 5-year survivors were followed up for 427,130 person-years; the median follow-up time was 5.7 years beyond the 5 Conclusions: The excess mortality is mostly due to the malignancy of the primary tumour, but an about 2-fold excess of mortality is also appreciable for non-cancer causes. Young adult cancer survivors face a sevenfold increase in all-cause mortality compared to the general population, with a notable rise in both cancer-related and non-cancer deaths. Thirty years post-diagnosis, the excess risk from cancer and non-cancer causes becomes nearly equal.

Indexed as

adolescent and young adultscancercohort studymortalitysurvivors

Identifiers

PMID40809018
PMCPMC12343270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.